Harmolol; ZINC00058176; Harmidol; NSC72293; TNP00138; KBio1_000998; Spectrum2_000556; SDCCGMLS-0066705.P001; KBio2_003469; KBio3_001462; KBio2_006037; 1-Methyl-4,9-dihydro-3H-beta-carbolin-7-ol hydrochloride; NSC 72293; Harmalol; AIDS099662; SPBio_002761; 3H-Pyrido(3,4-b)indol-7-ol, 4,9-dihydro-1-methyl- (8CI)(9CI); 3H-Pyrido[3,4-b]indol-7-ol, 4,9-dihydro-1-methyl-; DivK1c_000998; 6028-07-5; 2H-Pyrido[3,4-b]indol-7-ol, 3,4-dihydro-1-methyl-; 525-57-5; 6028-00-8; AIDS-099662; Spectrum3_000721; NCGC00017249-01; EINECS 208-375-4; NSC640461; KBio2_000901; 3H-Pyrido[3,4-b]indol-7-ol, 4, 9-dihydro-1-methyl-; Spectrum_000421; KBioGR_001154; Spectrum4_000767; KBioSS_000901; Prestwick0_000611; Prestwick1_000611; NCI60_013481; 4,9-Dihydro-1-methyl-3H-pyrido(3,4-b)indol-7-ol; NINDS_000998; SPBio_000631
show less «
